Participants for clinical trials are currently being recruited at Barrow Neurological Institute. Researchers are looking to evaluate a medication that could improve intellectual function in young adults with Down Syndrome.
Physicians at Barrow, located at St. Joseph’s Hospital and Medical Center, are looking for male or female participants between 18 and 30 years of age.
“To my knowledge, this is the first trial of its kind,” says Benjamin Seltzer, MD, Director of the Center of Alzheimer’s Disease and Cognitive Disorders at Barrow.
Seltzer says that Down syndrome is the most important cause of development delay. Many of the medical problems associated with Down syndrome, such as low thyroid and heart defects, can now be corrected.
Now, however, Seltzer says researchers have developed a medication that may provide a cognitive benefit. “A study like this has been needed for a long time.”
Down syndrome is a set of mental and physical symptoms that result from having an extra copy of Chromosome 21. There are more than 400,000 people living with Down syndrome in the United States. One in every 691 babies is born with Down syndrome.
The clinical trial at Barrow will last about 15 weeks. Participants will be required to take the newly developed medication twice daily. They will undergo periodic blood and memory testing and brain wave examinations.
The study is also being conducted at several other research centers in the United States and the United Kingdom.
Participants must be in good general health, between the ages of 18 and 30, and have a reliable person who can accompany them to all appointments.
For more information on how to enroll in this study, please call: Catherine Young at 602-406-3719.
More resources on Down syndrome: